10. Galenus Workshop (11.bis 13. September 2024)
Unter dem Titel „Exploring the Future of Inhalation Drug Delivery“ organisiert Frau Prof. Francesca Buttini vom Food and Drug Department der Universität Parma (Italien) einen dreitägigen Galenus Workshop in Parma. Details zum Programm der Veranstaltung, die in englischer Sprache stattfindet, werden in Kürze veröffentlicht. Veranstaltungsort ist das Auditorium del Carmine in der ehemaligen Kirche Santa Maria del Carmine sowie dem angeschlossenen Kloster mit seinen Kreuzgängen, in denen u.a. die Posterpräsentation stattfinden wird. Erwartet werden mehr als 230 Teilnehmer aus ganz Europa und den USA.
Programm
| WEDNESDAY, September 11 | ||
|---|---|---|
| SPEAKER | TITLE | TIME |
| Francesca Buttini (University of Parma) Cornelia Désirée Sonntag (Galenus Foundation) | Conference opening | 9:00-9:10 |
NEW PARADIGMS IN LUNG DELIVERY | ||
| David Edwards (Harvard University, US) | Chronic cough, airway rehydration, and climate change | 9:10-9:40 |
| Michael Hindle (Virginia Commonwealth University, US) | Development of a lung surfactant powder aerosol product for babies with respiratory distress syndrome | 9:40-10:05 |
| Pavan Muttil (University of New Mexico, US) | Formulation development and preclinical evaluation of aerosol vaccines: challenges, opportunities and lessons learnt | 10:05-10:30 |
| To be selected from abstracts submitted | 10:30-10:45 | |
| COFFEE BREAK + POSTER SESSION | ||
| Nicola Tsapis (Paris-Saclay University, France) | Nanomedicines and microparticles for the treatment of pulmonary infections | 11:25-11:50 |
| David Cipolla (Insmed, USA) | Preclinical and CMC development of treprostinil palmitil inhalation powder | 11:50-12:15 |
| Paul Hagedoorn (University of Groningen, The Netherlands) | The development of pulmonary levodopa applications for patients with Parkinson’s disease | 12:15-12:40 |
| LIGHT LUNCH + POSTER SESSION | ||
RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS | ||
| Tomaso Guidi (Chiesi, Italy) | Inhaled biologics: current trends in the industry | 14:20-14:40 |
| Francesca Buttini (University of Parma, Italy) | The formulation of protein and probiotics in dry powder inhalers | 14:40-15:05 |
| To be selected from abstracts submitted | 15:05-15:20 | |
| To be selected from abstracts submitted | 15:20-15:35 | |
| COFFEE BREAK + POSTER SESSION | ||
| Regina Scherließ (Kiel University, Germany) | Nasal vaccine technology | 16:15-16:40 |
| Ben Forbes (King’s College, UK) | Biologics from nose to brain | 16:40-17:05 |
| To be selected from the abstract submitted | 17:05-17:20 | |
| WELCOME RECEPTION | ||
| THURSDAY, September 12 | ||
|---|---|---|
| SPEAKER | TITLE | TIME |
BIOLOGICS LOVE LUNGS | ||
| Hugh Smyth (University of Texas at Austin, US) | Developing inhaled mAbs and nucleic acids for therapeutic success | 9:00-9:30 |
| Jenny Lam (University of Central London, UK) | How to make antibodies formulation stable and inhalable | 9:30-9:55 |
| To be selected from abstracts submitted | 9:55-10:10 | |
| To be selected from abstracts submitted | 10:10-10:25 | |
| COFFEE BREAK + POSTER SESSION | ||
ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI | ||
| Barzin Gavtash and Benjamin Myatt (Kindeva, UK) | Atomization properties and aerosol characteristics of new low GWP propellants | 11:05-11:30 |
| TBA (Chiesi, Italy) | Re-formulation of pMDI in HFA152a | 11:30-11:55 |
| David Lecthuga (Astra Zeneca, US) | pMDI: stable suspension in HFO1234ze | 11:55-12:20 |
| TBA RxPack (Italy) | Re-formulation of beclomethasone diproprionate ethanol-based solution in new eco-sustainable propellants | 12:20-12:35 |
| LIGHT LUNCH + POSTER SESSION | ||
LAST FRONTIERS IN LUNG INFECTION | ||
| Keertan Dheda (University of Cape Town, South Africa) | Challenges in the prevention and management of drug-sensitive and drugresistant TB | 14:20-14:45 |
| Lea Ann Daily (University of Vienna, Austria) | A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics | 14:45-15:10 |
| Francesca Ungaro (University of Naples, Italy) | Novel formulation approaches for lung infection treatment | 15:10-15:35 |
| Mirjam Kobler (H&T Presspart, UK) | The sunriser – achieving high performance in challenging formulations | 15:35-15:50 |
| COFFEE BREAK + POSTER SESSION | ||
| PhD Students Contest Seven7th | Seven talks of 7 minutes selected from abstract submission | 16:20-17:20 |
| GALA DINNER | ||
| FRIDAY, September 13 | ||
|---|---|---|
| SPEAKER | TITLE | TIME |
NEW RESEARCH | ||
| Federico Lavorini (University of Florence, Italy) | Physiological and technological barriers in the treatment of COPD | 9:00-9:30 |
| Jan de Backer (FLUIDDA, USA) | The role of digital twins and in-silico trials as regulatory tools for the authorization of orally inhaled drugs | 9:30-9:55 |
| Carsten Ehrhardt (Trinity College, Ireland) | Uptake mechanisms of molecules released into the lungs | 9:55-10:20 |
| COFFEE BREAK + POSTER SESSION | ||
| Daniela Traini (Macquarie University, Australia) | Non-clinical tests in the evaluation of inhaled pharmaceuticals | 11:00-11:25 |
| Per Backmann (Emmace, Sweden) | Physiologically-based biopharmaceutical models- a tool to understand local and systemic exposure of inhaled medicines | 11:25-11:50 |
| Amrit Paudel (RCPE, Austria) | Empowering drug-drug co-amorphous inhaled formulation design using datadriven approach | 11:50-12:15 |
| CLOSING REMARKS | ||